OxyContin Information
(800) 889-9248
The DEA has stepped in and is trying to increase the amount of information on OxyContin available to stop OxyContin abuse. Quickly becoming one of the most abused narcotics, insufficient information on OxyContin was given to doctors prescribing the powerful drug due to aggressive sales of the opiate painkillers according to some critics. OxyContin was seen as a breakthrough in pain management due to the controlled-release dosage form that could provide up to 12 hours of pain relief, but the information on OxyContin may not have stressed the dangers of the drug according to some.
Now, after much debate and controversy, the FDA has required that certain information on OxyContin be changed on the drugs labeling. The new information on OxyContin will include the strongest type of FDA warning called a black box warning. The information on OxyContin is intended to reduce the risks of improper prescribing. One criticism of OxyContin sales is that the company did not adequately communicate the information on OxyContin stressing that it is inappropriate for pain not considered for a Schedule II narcotic. OxyContin had annual sales of over $1 billion in 2000 as its best selling product, resulting from company misuse according to OxyContin opponents.
For more information on OxyContin contact us.
